![Patrick Chalmers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 392 $ al 31/07/2026
Patrick Chalmers has been Controller at Rocky Point Ventures LLC since 2014.
Mr. Chalmers earned an MBA degree in 2005 from The University of Texas at Austin.
Mr. Chalmers also completed an undergraduate degree at The University of Texas at Austin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices 0,03 % | 29/07/2026 | 5.100 ( 0,03 % ) | 1 392 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Rocky Point Ventures LLC
 Rocky Point Ventures LLC Investment ManagersFinance Rocky Point Ventures invests in lower middle market companies located in the United States, primarily in Texas and the Southeast region with an EBITA of USD 1.5 - 4 million. The firm focuses on manufacturing, distribution, wholesale, technology and biotechnology sectors. It participates in early stage and buyout transactions with transaction amount of USD 5 - 20 million. | Inversor de Capital Privado | 01/11/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rocky Point Ventures LLC
Rocky Point Ventures LLC Investment ManagersFinance Rocky Point Ventures invests in lower middle market companies located in the United States, primarily in Texas and the Southeast region with an EBITA of USD 1.5 - 4 million. The firm focuses on manufacturing, distribution, wholesale, technology and biotechnology sectors. It participates in early stage and buyout transactions with transaction amount of USD 5 - 20 million. | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
